ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: FR-PO1135

Comparative Assessment of Creatinine-Based eGFR and Cystatin C-Based eGFR in Sickle Cell Disease

Session Information

Category: CKD (Non-Dialysis)

  • 2301 CKD (Non-Dialysis): Epidemiology, Risk Factors, and Prevention

Authors

  • Schittine Bezerra Lomba, Guilherme, Universidade Federal Fluminense Hospital Universitario Antonio Pedro, Niterói, RJ, Brazil
  • Camisao Aquino, Larissa, Universidade Federal Fluminense Hospital Universitario Antonio Pedro, Niterói, RJ, Brazil
  • Vigo, Mariana C, Universidade Federal Fluminense Hospital Universitario Antonio Pedro, Niterói, RJ, Brazil
  • Mercante, Daniel, Universidade Federal Fluminense Hospital Universitario Antonio Pedro, Niterói, RJ, Brazil
  • Da Silva, Angelica P., Universidade Federal Fluminense Hospital Universitario Antonio Pedro, Niterói, RJ, Brazil
  • Gomes, Guilherme Wataru, Universidade Federal Fluminense Hospital Universitario Antonio Pedro, Niterói, RJ, Brazil
  • Lugon, Jocemir R., Universidade Federal Fluminense Hospital Universitario Antonio Pedro, Niterói, RJ, Brazil
Background

Accurate estimated glomerular filtration rate (eGFR) is essential in sickle cell disease (SCD), a condition in which patients are at risk for both hyperfiltration and progressive kidney injury. Creatinine-based eGFR (eGFR-Cr) may be unreliable in SCD due to reduced muscle mass, while cystatin C-based eGFR (eGFR-Cys) offers a muscle-mass–independent alternative. This study compares eGFR-Cr and c eGFR-Cys in patients with SCD to assess their agreement and clinical relevance.

Methods

We conducted a cross-sectional study of patients with SCD followed at a quaternary hospital between Sept/2024 and April/2025. eGFR was calculated using the CKD-EPI 2021 creatinine and CKD-EPI 2012 cystatin C equations on the same blood sample. Hyperfiltration was defined as GFR >140 for men and >130 for women. Comparisons between methods were assessed using the Mann-Whitney test and Bland-Altman analysis.

Results

We analyzed 45 patients with a median age of 35 (18-74) years, 69% female, 93% black. At study entry, 68.9% were using hydroxyurea, 15.5% Renin-Angiotensin system inhibitors, and no one was diagnosed with diabetes. 18.6% of patients were underweight, 55.8% had a normal BMI, and 25.6% were overweight. Median eGFR-Cr eGFR-Cys were 124 (IQR 105-133) mL/min/1.73m2 and 101 (IQR 69-118) mL/min/1.73m2, respectively (p <0.001). The Bland-Altman analysis is shown in Figure 1. The eGFR-Cr equation identified significantly more hyperfiltration cases than eGFR-Cyst equation (26.7% vs 8.9%, p <0.001). Microalbuminuria was found in 22% of cases, and macroalbuminuria in 13%. eGFR calculated by either Cr (R = -283, P=0.062) or Cyst (R = -107, P=0.490) was not significantly correlated with albuminuria.

Conclusion

Among patients with SCD, eGFR-Cr was significantly higher than eGFR-Cys, possibly overestimating the diagnosis of hyperfiltration. Cystatin C may be more accurate for eGFR assessment in SCD.

Digital Object Identifier (DOI)